Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Force-Regulated Transport in Tunneling Nanotubes
2026-08-25
The reference study combines optical trapping, confocal imaging, microtubule-polarity mapping, and viscoelastic calibration to quantify lipid-droplet transport through tunneling nanotubes. Its force measurements show that kinesin and dynein cooperate as dynamically coupled motor ensembles, providing a mechanical explanation for bidirectional, long-range cargo movement in confined intercellular bridges.
-
TCEP Hydrochloride: Mechanism and Workflows
2026-08-25
Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a water-soluble, thiol-free reagent for disulfide bond reduction. Its product specifications support protein analysis, protein digestion enhancement, hydrogen-deuterium exchange analysis, and selected organic synthesis workflows, while current lateral-flow evidence supports capture-and-release concepts rather than direct validation of TCEP itself.
-
Adiponectin, TLR4, and Cognitive Deficits in Aged Rats
2026-08-24
This reference study shows that adiponectin pretreatment reduced splenectomy-associated cognitive impairment in aged rats, with accompanying decreases in hippocampal neuroinflammation, oxidative stress, and apoptosis. Pharmacological inhibition and activation of TLR4 support a mechanistic role for the TLR4/MyD88/NF-κB axis, while also indicating that the findings remain preclinical and pathway-focused.
-
Ruxolitinib, DRP1, and Cell Death in Anaplastic Thyroid Canc
2026-08-24
The reference study identifies a JAK1/2-STAT3-DRP1 axis through which ruxolitinib suppresses mitochondrial fission and induces both apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma. Its principal contribution is to connect JAK/STAT signaling pathway modulation with transcriptional control of mitochondrial dynamics, providing a mechanistic basis for further preclinical investigation rather than clinical proof.
-
Sex Differences in Angiotensin II Hypertension
2026-08-23
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II produced a substantially larger hypertensive response in conscious male mice than in females, while gonadectomy reversed much of this pattern. Telemetry, baroreflex testing, and ganglionic blockade linked the blood-pressure difference to sex-dependent autonomic regulation rather than to baseline blood pressure alone.
-
Tamoxifen in Neuroimmune Assay Design
2026-08-22
Tamoxifen is more than a selective estrogen receptor modulator for cancer and conditional genetics: it can also shape how researchers interpret inducible neuroimmune experiments. This article uses a recent colitis study to develop a control-centered framework for separating CreER biology from intestinal inflammation mechanisms.
-
Ruxolitinib Triggers DRP1-Linked Death in ATC
2026-08-22
The reference study identifies a previously unrecognized connection between JAK1/2-STAT3 signaling, DRP1-dependent mitochondrial fission, and dual apoptotic–pyroptotic death in anaplastic thyroid carcinoma. Its in vitro and in vivo findings position ruxolitinib as a mechanistic tool for testing mitochondrial dynamics and GSDME-associated cell death in this aggressive tumor type.
-
High-Dose Maternal Tamoxifen and Mouse Malformations
2026-08-21
Sun et al. show that a single high dose of maternal Tamoxifen at a defined embryonic stage produces highly penetrant craniofacial and limb malformations in mouse fetuses, whereas a lower dose did not cause overt structural defects. The study establishes an important developmental safety consideration for Tamoxifen use in CreER-mediated gene knockout and other translational research settings.
-
PD 173074 Workflow for FGFR1 and VEGFR2 Studies
2026-08-20
PD 173074 enables concentration-resolved interrogation of FGFR1 and VEGFR2 signaling, from acute phosphorylation assays to angiogenesis and lung adenocarcinoma models. This workflow connects pharmacologic target validation with the CENPO-associated biology described in recent LUAD research while separating direct evidence from exploratory applications.
-
Tofacitinib for Reliable Immune Cell Assays
2026-08-20
This scenario-based guide explains how Tofacitinib (CP-690550, Tasocitinib), SKU A4138, can support reproducible immune cell proliferation, viability, and cytokine-signaling experiments. It connects model-specific IC50 data with practical stock preparation, controls, interpretation, and vendor-selection criteria.
-
AG-490: Practical JAK2/EGFR Assay Design
2026-08-19
A scenario-driven guide to using AG-490 (JAK2/EGFR inhibitor), SKU A4139, in viability, proliferation, and pathway-validation workflows. It connects reported kinase and cytokine-response data with practical controls for solubility, dose selection, interpretation, and vendor evaluation.
-
SIS3: Smad3 Inhibitor for TGF-β Research
2026-08-19
SIS3 is a selective Smad3 inhibitor that targets TGF-β/Smad3 signaling without reported inhibition of Smad2 phosphorylation. Peer-reviewed osteoarthritis experiments link SIS3 treatment with lower ADAMTS-5 expression and higher miRNA-140 expression, while product data support broader preclinical fibrosis research applications.
-
Sulfo-NHS-SS-Biotin for Surface-Proteome Logic
2026-08-18
Sulfo-NHS-SS-Biotin enables water-soluble, reversible labeling of extracellular proteins while preserving a route to distinguish surface residency from molecular association. This guide connects the K1006 workflow to glycoRNA–RNA-binding-protein nanodomains and explains how to design more discriminating cell-surface assays.
-
HotStart 2X Green qPCR Master Mix in Pain Translation
2026-08-18
A translational framework for using SYBR Green qPCR to connect NTSR1–β-arrestin-2 pain biology with reproducible molecular validation, while recognizing the limits of transcript-level evidence.
-
5-hme-dCTP: A Better Way to Read 5hmC
2026-08-17
5-hme-dCTP enables controlled DNA polymerase studies of 5-hydroxymethylcytosine without confusing synthetic nucleotide incorporation with native epigenetic mapping. This guide translates rice drought-response findings into practical assay-selection and reagent-handling decisions.